10.29.26 -- 6 Oligonucleotide Scale-Up Lessons For Sponsors

By working with a single supplier that can handle the entire manufacturing value chain, companies can reduce risk, improve flexibility, and accelerate their time to market.

Outsourcing resin lifetime studies accelerates timelines, reduces costs, and minimizes risk. Gain expert support, free up resources, and optimize resin performance without tying up your team or equipment.

Outsourced process characterization can save time, but only with the right preparation. Clear expectations around materials and data interpretation help reduce rework and strengthen confidence.

Explore strategies for securing recombinant proteins while addressing supply continuity, batch consistency, scale-up challenges, and quality requirements for clinical validation and commercialization.

Deeper, automated E. coli screening can reduce costs by narrowing the design space, lowering the marginal cost of additional experiments, and improving downstream productivity through higher titers.

A pioneering perspective explores how scientific thinking, physics‑based insights, and bold leadership are expanding the druggable universe and opening therapeutic paths once thought impossible.

A practical guide to antibody manufacturing — mammalian platforms, downstream efficiency, viral safety, and analytics — plus proven practices to reduce scale‑up risk and ensure consistent GMP supply.

ATMPs challenge existing E&L practices in single-use manufacturing. Gain expert insight into regulatory gaps, risk management needs, and the urgency for tailored approaches.

Flexible development and manufacturing are essential for complex biologics. See scalable processes, advanced cell line strategies, and partnership models that move programs efficiently.

Development partnerships start with early alignment, transparency, and shared accountability, reducing risk, improving scalability, and supporting success as programs advance.

Upstream decisions directly dictate late-stage sterile fill/finish success. Learn how aligning drug substance synthesis, formulation design, and aseptic filling early mitigates operational risks.